C. Orciuolo

Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.

M. Fassan, M. Zampino, V. Formica, 2023, European journal of cancer.

Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

M. Fassan, V. Zagonel, M. Zampino, 2021, Journal for ImmunoTherapy of Cancer.

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study

M. Filetti, P. Ascierto, J. Aerts, 2023, Journal of the National Cancer Institute.